The Oncology Institute
TOI
49 hedge funds and large institutions have $205M invested in The Oncology Institute in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 5 closing their positions.
220% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 5
154% more capital invested
Capital invested by funds: $80.8M → $205M (+$124M)
41.79% more ownership
Funds ownership: 40.75% → 82.55% (+42%)
29% more funds holding
Funds holding: 38 → 49 (+11)
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$56.2M |
| 2 |
SRCM
Sage Rock Capital Management
New York
|
+$10.5M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$9.23M |
| 4 |
ECM
Element Capital Management
New York
|
+$8.75M |
| 5 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$3.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$3.05M |
| 2 |
FTCM
Fir Tree Capital Management
New York
|
-$2.59M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.03M |
| 4 |
SCM
Saba Capital Management
New York
|
-$828K |
| 5 |
AGM
Alpine Global Management
New York
|
-$664K |
TOI Hedge Fund Activity: Q4 2020 in Review
49 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute (TOI) for Q4 2020, worth a combined $205M — up 154% from $80.8M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new TOI positions and 5 closed out — a net gain of 11 holders — while 6 added to existing stakes and 11 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $56.2M. The largest seller was UBS O'Connor, cutting an estimated $3.05M.
- 49 institutional investors held The Oncology Institute (TOI) as of Q4 2020, up from 38 in Q3 2020.
- Funds reported $205M of The Oncology Institute stock for Q4 2020, up 154% quarter-over-quarter.
- 16 funds opened new The Oncology Institute positions in Q4 2020 and 5 closed out, a net change of +11 holders.
- The largest The Oncology Institute buyer in Q4 2020 was Deerfield Management, an estimated $56.2M added.
- The largest The Oncology Institute seller in Q4 2020 was UBS O'Connor, an estimated $3.05M sold.
Based on aggregated 13F filings for Q4 2020.